{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:43:45Z","timestamp":1763142225921,"version":"3.41.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>An 81-year-old woman experienced compression symptoms due to diffuse enlargement of the thyroid gland. The cytopathological results of thyroid fine-needle suggested malignancy. Therefore, she underwent bilateral thyroidectomy. Postoperative pathology indicated mucosa-associated lymphoid tissue (MALT) lymphoma. Three months later, she found a progressively enlarged mass in her neck. The biopsy showed MALT lymphoma with highly aggressive B-cell lymphoma transformation. <jats:sup>18<\/jats:sup>F-FDG PET\/CT showed increased metabolism in multiple lymph nodes. However, some of these lymph nodes were negative in <jats:sup>68<\/jats:sup>Ga-pentxafor PET\/CT. Our case demonstrated that <jats:sup>68<\/jats:sup>Ga-pentixafor may have limited value in evaluating MALT lymphoma transformation.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005057","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T19:03:14Z","timestamp":1706900594000},"page":"276-277","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["MALT Lymphoma in Histologic Transformation"],"prefix":"10.1097","volume":"49","author":[{"given":"Ranbie","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengna","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoqiao","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"bib1-20250621","first-page":"153","article-title":"Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","volume":"66","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","article-title":"Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature","volume":"122","year":"2013","journal-title":"Blood"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1097\/RLU.0b013e31821c99cd","article-title":"Imaging of extranodal lymphoma with PET\/CT","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas\u2020","volume":"26","year":"2015","journal-title":"Ann Oncol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/annonc\/mdt507","article-title":"Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2016.06.006","article-title":"CXCR4 signaling in health and disease","volume":"177","year":"2016","journal-title":"Immunol Lett"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-020-00681-7","article-title":"Preliminary evidence of imaging of chemokine receptor-4-targeted PET\/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG","volume":"10","year":"2020","journal-title":"EJNMMI Res"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/thno.11251","article-title":"Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging","volume":"5","year":"2015","journal-title":"Theranostics"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.3390\/cancers14153814","article-title":"The role of [68Ga]Ga-pentixafor PET\/CT or PET\/MRI in lymphoma: a systematic review","volume":"14","year":"2022","journal-title":"Cancers (Basel)"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.120.257279","article-title":"Improved primary staging of marginal-zone lymphoma by addition of CXCR4-directed PET\/CT","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/RLU.0000000000004638","article-title":"68Ga-pentixafor PET\/MRI for treatment response assessment in mantle cell lymphoma: comparison between changes in lesion CXCR4 expression on PET and lesion size and diffusivity on MRI","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/RLU.0000000000003760","article-title":"Chemokine receptor 4-targeted 68Ga-pentixafor PET\/CT in response assessment of Waldenstr\u00f6m macroglobulinemia\/lymphoplasmacytic lymphoma: comparison to 18F-FDG PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/RLU.0000000000003404","article-title":"Assessment of central nervous system lymphoma based on CXCR4 expression in vivo using 68Ga-pentixafor PET\/MRI","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/modpathol.2012.134","article-title":"Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma","volume":"26","year":"2013","journal-title":"Mod Pathol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:03:30Z","timestamp":1750532610000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005057"}},"subtitle":["FDG-Avid but Pentixafor-Negative"],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005057","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2024,1,15]]}}}